ArticleCureus2025

Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.

Sorcha O'Connor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.